These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21792513)

  • 1. Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma.
    Gao Q; Zhou J; Wang XY; Qiu SJ; Song K; Huang XW; Sun J; Shi YH; Li BZ; Xiao YS; Fan J
    Ann Surg Oncol; 2012 Feb; 19(2):455-66. PubMed ID: 21792513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma.
    Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM
    Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.
    Li YW; Qiu SJ; Fan J; Zhou J; Gao Q; Xiao YS; Xu YF
    J Hepatol; 2011 Mar; 54(3):497-505. PubMed ID: 21112656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation.
    Unitt E; Marshall A; Gelson W; Rushbrook SM; Davies S; Vowler SL; Morris LS; Coleman N; Alexander GJ
    J Hepatol; 2006 Aug; 45(2):246-53. PubMed ID: 16580084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
    Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY
    J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma.
    Shi JY; Gao Q; Wang ZC; Zhou J; Wang XY; Min ZH; Shi YH; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Song K; Fan J
    Clin Cancer Res; 2013 Nov; 19(21):5994-6005. PubMed ID: 24056784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection.
    Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
    Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
    Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.
    Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS
    Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of tumor-infiltrating lymphocytes for survival in curatively resected stage IV colon cancer with isolated liver or lung metastasis.
    Lee WS; Kang M; Baek JH; Lee JI; Ha SY
    Ann Surg Oncol; 2013 Feb; 20(2):697-702. PubMed ID: 23224827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.
    Ding T; Xu J; Wang F; Shi M; Zhang Y; Li SP; Zheng L
    Hum Pathol; 2009 Mar; 40(3):381-9. PubMed ID: 18992916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
    Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH
    Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between dendritic cells and memory T lymphocytes in tumor site and prognosis of hepatocellular carcinoma].
    Cai XY; Qiu SJ; Wu ZQ; Ye SL; Fan J; Zhou J; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):671-5. PubMed ID: 15932729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.
    Li L; Yan J; Xu J; Liu CQ; Zhen ZJ; Chen HW; Ji Y; Wu ZP; Hu JY; Zheng L; Lau WY
    PLoS One; 2014; 9(10):e110064. PubMed ID: 25303284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
    Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
    de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
    Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
    Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
    Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection.
    Yang Y; Nagano H; Ota H; Morimoto O; Nakamura M; Wada H; Noda T; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshita K; Nakamori S; Wakasa K; Sakon M; Monden M
    Surgery; 2007 Feb; 141(2):196-202. PubMed ID: 17263976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.